Researchers from Oregon Health and Science University Knight Cancer Institute have found that a gene called Src plays a role in helping some kidney cancers grow. The researchers are now looking at existing, approved drugs that may inhibit Src activity in cancer cells. In addition, they have developed a method of identifying patients that could benefit from such drugs. This discovery could expand kidney cancer drug treatments beyond therapies that slow tumor growth, but fail to provide a cure, and don’t work for all patients.
Kidney Cancer Discovery Could Expand Treatment Options, Science Daily, July 7, 2011